#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1024879	F	Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay	Vaccinia virus	93	ALA1140145	organism-based format	Scientific Literature
2.	ALA1024886	F	Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as reduction in plaque formation up to 200 uM after 20 hrs	Vaccinia virus	19	ALA1140145	organism-based format	Scientific Literature
3.	ALA1024887	F	Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as protection from virus-induced lysis of cell monolayer up to 200 uM after 20 hrs	Vaccinia virus	19	ALA1140145	organism-based format	Scientific Literature
4.	ALA1024888	A	Cytotoxicity against african green monkey BSC1 cells up to 200 uM after 20 to 120 hrs WST-1 based assay	Chlorocebus aethiops	19	ALA1140145	cell-based format	Scientific Literature
5.	ALA3097397	A	Cytotoxicity against mouse stationary-phase ScN2a-cl3 cells assessed as cell viability at 10 uM after 5 days by calcein-AM staining-based fluorescence assay	Mus musculus	23	ALA3091297	cell-based format	Scientific Literature
6.	ALA3097398	B	Inhibition of RML prion protein infected in mouse stationary-phase ScN2a-cl3 cells expressing full length mouse PrP assessed as reduction of PrPsc level at 10 uM after 5 days by ELISA	Mus musculus	23	ALA3091297	cell-based format	Scientific Literature
7.	ALA3097399	A	Cytotoxicity against mouse dividing ScN2a-cl3 cells assessed as cell viability at 10 uM after 5 days by calcein-AM staining-based fluorescence assay	Mus musculus	23	ALA3091297	cell-based format	Scientific Literature
8.	ALA3097404	B	Inhibition of RML prion protein infected in mouse dividing ScN2a-cl3 cells expressing full length mouse PrP assessed as reduction of PrPsc level at 10 uM after 5 days by ELISA	Mus musculus	23	ALA3091297	cell-based format	Scientific Literature
9.	ALA3887699	B	Inhibition Assay: A rapid plate DNA synthesis assay was performed using optimized conditions. Briefly, a 1.2:1 ratio of a 20-mer oligonucleotide primer (5′-GCGAATGAATGACCGCTGAC-3′, SEQ ID No. 1) and a 5′-end biotinylated 100-mer oligonucleotide template (5′-Biotin-AGCACTATTGACATTACAGAGTCGCCTTGGCTCTCTGGCTGTTCGTTGCGGGCTCCGCG TGCGTTGGCTTCGGTCGTCCCGTCAGCGGTCATTCATTGGC-3′) were annealed and loaded into a 96-well microtiter streptavidin-coated plate (Streptawell plates, Roche Applied Science, Indianapolis, Ind., USA) at 5 pmol/well. The wells were incubated at 37 C for 90 min, and washed with 100 L PBS. The reaction was conducted in low salt buffer (20 mM Tris-HCl pH 7.4, 3 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 2% glycerol, 40 ug/mL BSA, 5 uM dNTPs, 1 uM digoxigenin-11-2′-deoxyuridine-5′-triphosphate (DIG-dUTP, Roche Applied Science) with 1 μL vaccinia infected cell lysate or 1 uL of in vitro translated E9 DNA polymerase. The reaction plates were incubated at 37° C		35	ALA3886410	assay format	BindingDB Database